Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Recombinant Human Endostatin in Non-Small Cell Lung Cancer With Leptomeningeal Metastasis

NCT04356118 is registered in ClinicalTrials.gov with Hui Bu as lead sponsor.

NCT NCT04356118
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04356118 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Recombinant Human Endostatin in Non-Small Cell Lung Cancer With Leptomeningeal Metastasis
Lead sponsor
Hui Bu
Phase
Phase 4
Overall status
Unknown status
Start date
June 30, 2020
Completion date
June 30, 2023
Enrollment
30 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

leptomeningeal metastasis